Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,622 US PATENTS IN FORCE
- 47,756 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 219,442 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
Not Available
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0189,201 | HAIR SERUM AND SUPPLEMENT | Apr 13, 22 | Jun 13, 24 | Not available |
| 2024/0189,220 | COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE | Jan 16, 24 | Jun 13, 24 | PHI THERAPEUTICS, INC. |
| 2024/0189,221 | METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE | Jul 07, 23 | Jun 13, 24 | Not available |
| 2024/0189,226 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY OR NON-ALCOHOLIC FATTY LIVER CONTAINING POLYGALIN C AS ACTIVE INGREDIENT | Apr 08, 22 | Jun 13, 24 | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG-HEE UNIVERSITY |
| 2024/0189,228 | SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF | Feb 26, 24 | Jun 13, 24 | SOFAR SWISS SA |
| 2024/0189,230 | PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER | Aug 11, 20 | Jun 13, 24 | Not available |
| 2024/0189,231 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | Sep 19, 23 | Jun 13, 24 | Not available |
| 2024/0189,237 | FORMULATION AND METHOD FOR TREATMENT OF URINARY SYSTEM DISORDERS | Apr 07, 21 | Jun 13, 24 | Watershed Medical, Inc. |
| 2024/0189,240 | PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN | Mar 24, 22 | Jun 13, 24 | Not available |
| 2024/0189,244 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS | Apr 08, 22 | Jun 13, 24 | Not available |
| 2024/0189,245 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE THEREOF | Jun 14, 22 | Jun 13, 24 | Not available |
| 2024/0189,246 | Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis | Nov 16, 23 | Jun 13, 24 | Not available |
| 2024/0189,250 | AQUEOUS WOUND HEALING FORMULATION | Dec 08, 23 | Jun 13, 24 | Not available |
| 2024/0189,251 | Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine | Feb 20, 24 | Jun 13, 24 | Not available |
| 2024/0189,254 | Xylitol Topical Ocular Solution | Jun 14, 22 | Jun 13, 24 | Not available |
| 2024/0189,255 | METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL | Jun 13, 23 | Jun 13, 24 | Zynerba Pharmaceuticals, Inc. |
| 2024/0189,256 | COMPOSITIONS FOR PRE-SURGICAL NUTRITIONAL SUPPLEMENTS | Dec 07, 23 | Jun 13, 24 | Not available |
| 2024/0189,257 | COMPOSITIONS AND METHODS FOR MANAGING NEPHROPATHY | Mar 25, 21 | Jun 13, 24 | Not available |
| 2024/0189,258 | CANCER CELL GROWTH INHIBITING COMPOSITION AND PROCESSED FOOD | Mar 16, 22 | Jun 13, 24 | HAGIHARA FARM PRODUCTION INSTITUTE CO., LTD.; Kinki University; |
| 2024/0189,259 | Extended Release Pharmaceutical Formulation | Sep 22, 21 | Jun 13, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)